Skip to main content

McKesson Value Stock - Dividend - Research Selection

Mckesson

ISIN: US58155Q1031 , WKN: 893953

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs, and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. This segment also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, this segment operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks in North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. This segment serves retail national accounts, including national and regional chains, food/drug combinations, mail order pharmacies, and mass merchandisers; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as offers its services to pharmaceutical manufacturers. The McKesson Technology Solutions segment provides clinical, financial, and supply chain management solutions to healthcare organizations. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


McKesson Shares Fall Following Sale of Rexall, Well.ca to Birch Hill

2024-09-06
MCK announces the sale of its Canada-based Rexall and Well.ca businesses to Birch Hill Equity Partners, aligning with its strategy to grow oncology and biopharma services.

McKesson price target lowered by $168 at Baird, here's why

2024-09-06
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Election 2024: Where To Put Your Money Ahead of the Vote

2024-09-06
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

S&P 500 Gains and Losses Today: McKesson Falls Amid Plans To Exit Canada Businesses

2024-09-05
The S&P 500 slid 0.3% on Thursday, Sept. 5, with soft private payroll data adding to concerns about the labor market ahead of Friday's jobs report.

McKesson, Zimmer Biomet shares tumble

2024-09-05
Shares of McKesson (MCK) fell sharply on Thursday. The healthcare services company issued a Q2 earnings forecast that underwhelmed investors. Meanwhile, Zimmer Biomet (ZBH) shares sank after the medical products company warned that issues with an enterprise resource system would hit its financial results. Market Domination anchors Julie Hyman and Josh Lipton break down the announcements in the video above. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Stephanie Mikulich.

US Equity Indexes Mixed Following Surprise Deceleration in Private Jobs

2024-09-05
US Equity Indexes Mixed Following Surprise Deceleration in Private Jobs

15 Unhealthiest Countries In Africa

2024-09-05
In this article, we will be taking a look at the 15 unhealthiest countries in Africa. You can skip our detailed analysis on the topic and directly head to the 5 Unhealthiest Countries In Africa. Global Healthcare Market Expansion and Africa’s Emerging Growth Opportunities The global healthcare market is extensive and expanding rapidly. In 2023, […]

McKesson sees Q2 adjusted EPS of $6.70-$7, consensus $7.39

2024-09-05
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

McKesson slips as Q2 outlook underwhelms

2024-09-05
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

McKesson Corporation (MCK) Wells Fargo 2024 Healthcare Conference (Transcript)

2024-09-05
McKesson Corporation (NYSE:MCK) Wells Fargo 2024 Healthcare Conference September 5, 2024 8:45 AM ETCompany ParticipantsBritt Vitalone - Executive Vice...